HealthWise KnowledgeBase
Raloxifene
References
Citations
Drugs for postmenopausal osteoporosis (2011). Treatment Guidelines From The Medical Letter, 9(111): 67–74.
Vogel VG, et al. (2006). Effects of tamoxifen vs. raloxifene on the risk of developing invasive breast cancer and other disease outcomes: The NASBP study of tamoxifen and raloxifene (STAR) P-2 trial. JAMA, 295(23): 2727–2741.
| By: | Reference Healthwise Staff | Last Revised: November 6, 2012 |
| Medical Review: | Reference Kathleen Romito, MD - Family Medicine
Reference Carla J. Herman, MD, MPH - Geriatric Medicine |
|
© 1995-2011, Healthwise, Incorporated. Healthwise, Healthwise for every health decision, and the Healthwise logo are trademarks of Healthwise, Incorporated.
This information does not replace the advice of a doctor. Healthwise, Incorporated disclaims any warranty or liability for your use of this information. Your use of this information means that you agree to the Reference Terms of Use. Reference How this information was developed to help you make better health decisions.
